Preliminary study on radioguided sentinel node identification in colon cancer

Area of Science:

• Oncology
• Surgical Oncology
• Nuclear Medicine

Background:

• Nodal metastases significantly impact colon cancer prognosis, with current staging missing micrometastases in up to 30% of patients.
• Accurate lymph node staging is crucial for determining patient prognosis and guiding treatment decisions.
• Sentinel lymph node (SN) mapping offers a targeted approach to assess the status of the entire nodal basin.

Purpose of the Study:

• To establish the prognostic value of sentinel nodes (SN) in colon tumors.
• To validate the efficacy of radioguided surgery in identifying SN for colon cancer staging.
• To assess the feasibility of using SN biopsy for detecting micrometastases.

Main Methods:

• Twenty colon cancer patients received intraoperative injections of blue dye and 99mTc-colloidal particles for SN identification.
• SNs were localized using visual inspection (blue dye) and a handheld gamma probe.
• Radioisotope confirmation and assessment for aberrant lymphatic drainage were performed post-excision.

Main Results:

• Radioguided surgery successfully identified the SN in 95% of patients (19/20).
• One false-negative case was recorded, with a micrometastasis found in the SN being the only extracolonic site.
• Blue dye identified SNs in 14 cases, with radioisotope confirmation ensuring accuracy.

Conclusions:

• Sentinel node identification via radioguided surgery is a safe, rapid, and straightforward procedure for ultrastaging colon cancer nodal basins.
• This technique has a low learning curve and can be cost-effectively implemented as standard care.
• SN mapping improves the detection of nodal micrometastases, potentially benefiting patient outcomes and healthcare accessibility.